Skip to main content
Journal ArticleOPEN ACCESS

Q&A: Perry Nisen

  • Bender E
Nature (2015) 527(7576) S18-S18
DOI: 10.1038/527s18a
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A former paediatric oncologist and molecular biologist with experience in academia and industry, Perry Nisen was senior vice-president for science and innovation at GlaxoSmithKline in 2014 before becoming chief executive at the Sanford Burnham Prebys Medical Discovery Institute in La Jolla, California. He discusses the challenges facing drug discovery in the era of big data.

Cite

CITATION STYLE

APA

Bender, E. (2015). Q&A: Perry Nisen. Nature, 527(7576), S18–S18. https://doi.org/10.1038/527s18a

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free